read more

first_img IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology. Technology | September 23, 2009 Definiens to Showcase New LymphExpert Version 2 Technology | Mammography Reporting Software | June 12, 2019 Three Palm Software Releases WorkstationOne Version 1.8.8 Three Palm Software announced the release of the 1.8.8 version of its breast imaging workstation, WorkstationOne. This… read more News | Artificial Intelligence | August 13, 2019 Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that… read more Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev AI Models Predict Breast Cancer With Radiologist-level Accuracy Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer… read more Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire. Definiens is debuting its newly launched Version 2 of Definiens LymphExpert, a CAD software application designed to identify, analyze and measure the size of lymph nodes in CT images over time, making it easier to detect the metastatic spread of cancer. Definiens LymphExpert Version 2 is based on a thin-client architecture which gives radiologists remote access to image analysis and 3D rendering on a central server. Radiologists can access the software anytime and anywhere, with fast access to all patient images and tools across multiple interconnected sites and the Internet.Definiens LymphExpert analyzes lymph nodes in 3D and visualizes their volume, providing a truer picture than current RECIST and WHO guidelines, which are only one- and two-dimensional. The new version of Definiens LymphExpert enables users to conduct analysis of different time points with automatic calculation of comparative results allowing judgment of tumor progression, remission or stable disease.With Definiens LymphExpert Version 2, interactive processing and visualization computing takes place on an application server rather than having imaging data transmitted to the client upfront for processing. Image analysis results can now be obtained even faster and at a lower hardware cost. Definiens LymphExpert Version 2 also features predefined diagnostic reports with an easy “drag and drop” function to insert analyzed images or result comparison tables with various export functionalities. For more information: visit www.definiens.com FacebookTwitterLinkedInPrint分享 News | Breast Imaging | August 02, 2019 Volpara to Distribute Screenpoint Medical’s Transpara AI Solution Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint’s Transpara… read more News | Artificial Intelligence | August 05, 2019 Montefiore Nyack Hospital Uses Aidoc AI to Spot Urgent Conditions Faster Montefiore Nyack Hospital, an acute care hospital in Rockland County, N.Y., announced it is utilizing artificial… read more Technology | Computer-Aided Detection Software | May 21, 2019 MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August… read more Technology | Artificial Intelligence | July 18, 2019 Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded… read more News | Mammography | July 10, 2019 SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-… read more News | Artificial Intelligence | July 26, 2019 Progenics Pharmaceuticals Collaborating With Veterans Affairs on AI Cancer Imaging Research Program Oncology company Progenics Pharmaceuticals Inc. announced their collaboration with the Veterans Affairs Greater Los… read more Related Content News | Artificial Intelligence | June 13, 2019 iCAD Introduces ProFound AI for 2D Mammography in Europe iCAD Inc. announced the launch of ProFound AI for 2D Mammography in Europe. This software is the latest addition to… read more last_img read more